1. Home
  2. ZLAB vs AVPT Comparison

ZLAB vs AVPT Comparison

Compare ZLAB & AVPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • AVPT
  • Stock Information
  • Founded
  • ZLAB 2013
  • AVPT 2001
  • Country
  • ZLAB China
  • AVPT United States
  • Employees
  • ZLAB N/A
  • AVPT N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • AVPT Computer Software: Prepackaged Software
  • Sector
  • ZLAB Health Care
  • AVPT Technology
  • Exchange
  • ZLAB Nasdaq
  • AVPT Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • AVPT 3.8B
  • IPO Year
  • ZLAB 2017
  • AVPT N/A
  • Fundamental
  • Price
  • ZLAB $35.19
  • AVPT $18.51
  • Analyst Decision
  • ZLAB Buy
  • AVPT Buy
  • Analyst Count
  • ZLAB 5
  • AVPT 5
  • Target Price
  • ZLAB $54.28
  • AVPT $17.40
  • AVG Volume (30 Days)
  • ZLAB 689.4K
  • AVPT 1.2M
  • Earning Date
  • ZLAB 08-07-2025
  • AVPT 08-07-2025
  • Dividend Yield
  • ZLAB N/A
  • AVPT N/A
  • EPS Growth
  • ZLAB N/A
  • AVPT N/A
  • EPS
  • ZLAB N/A
  • AVPT N/A
  • Revenue
  • ZLAB $418,326,000.00
  • AVPT $349,012,000.00
  • Revenue This Year
  • ZLAB $44.07
  • AVPT $23.89
  • Revenue Next Year
  • ZLAB $49.13
  • AVPT $17.91
  • P/E Ratio
  • ZLAB N/A
  • AVPT N/A
  • Revenue Growth
  • ZLAB 43.72
  • AVPT 21.70
  • 52 Week Low
  • ZLAB $16.01
  • AVPT $9.38
  • 52 Week High
  • ZLAB $44.34
  • AVPT $20.25
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 49.90
  • AVPT 49.14
  • Support Level
  • ZLAB $32.31
  • AVPT $17.78
  • Resistance Level
  • ZLAB $35.72
  • AVPT $19.05
  • Average True Range (ATR)
  • ZLAB 1.10
  • AVPT 0.55
  • MACD
  • ZLAB -0.34
  • AVPT -0.09
  • Stochastic Oscillator
  • ZLAB 60.17
  • AVPT 37.24

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About AVPT AvePoint Inc.

AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.

Share on Social Networks: